cisapride has been researched along with Abdominal Pain in 10 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Abdominal Pain: Sensation of discomfort, distress, or agony in the abdominal region.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although combination antiemetics prevent vomiting during the initial 24 h after high-dose (> or =100 mg/m2) cisplatin, many patients experience delayed emesis 24-120 h afterwards despite receiving prophylactic dexamethasone and metoclopramide during this time." | 9.09 | Oral cisapride for the control of delayed vomiting following high-dose cisplatin. ( Baltzer, L; Grant, SC; Hinckley, L; Kris, MG; Miller, VA; Pisters, KM; Pizzo, BA, 1999) |
| "A controlled multi-centre clinical trial was conducted for evaluating the efficacy and safety of cisapride in the treatment of 414 cases of functional dyspepsia with 169 cases as control." | 9.08 | [A controlled multi-centre clinical trial on cisapride in treatment of functional dyspepsia]. ( Jia, B; Liang, X; Wang, B, 1995) |
| "To study the effect of prokinetic treatment with cisapride in patients with constipation-predominant irritable bowel syndrome." | 9.08 | Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome. ( Brandstätter, G; Dragosics, B; Hentschel, E; Judmaier, G; Schütze, K, 1997) |
| "The effects of prokinetic treatment with cisapride in patients with constipation-predominant irritable bowel syndrome (IBS) were evaluated in a randomized, double-blind, placebo-controlled study." | 9.07 | "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. ( Milo, R; Toussaint, J; Van Eeghem, P; Van Outryve, M, 1991) |
| "Cisapride has well-documented prokinetic effects and may be well suited for long-term therapy of GORD, but its effectiveness in purely symptomatic treatment is unknown." | 6.68 | The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease. ( Carling, L; Hatlebakk, JG; Johnsson, F; Thøgersen, T; Vilien, M; Wetterhus, S, 1997) |
| "Cisapride was well tolerated." | 6.67 | Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients. ( Cochran, KM; Penney, SC; Wood, SF, 1993) |
| "Although combination antiemetics prevent vomiting during the initial 24 h after high-dose (> or =100 mg/m2) cisplatin, many patients experience delayed emesis 24-120 h afterwards despite receiving prophylactic dexamethasone and metoclopramide during this time." | 5.09 | Oral cisapride for the control of delayed vomiting following high-dose cisplatin. ( Baltzer, L; Grant, SC; Hinckley, L; Kris, MG; Miller, VA; Pisters, KM; Pizzo, BA, 1999) |
| "A controlled multi-centre clinical trial was conducted for evaluating the efficacy and safety of cisapride in the treatment of 414 cases of functional dyspepsia with 169 cases as control." | 5.08 | [A controlled multi-centre clinical trial on cisapride in treatment of functional dyspepsia]. ( Jia, B; Liang, X; Wang, B, 1995) |
| "To study the effect of prokinetic treatment with cisapride in patients with constipation-predominant irritable bowel syndrome." | 5.08 | Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome. ( Brandstätter, G; Dragosics, B; Hentschel, E; Judmaier, G; Schütze, K, 1997) |
| "The effects of prokinetic treatment with cisapride in patients with constipation-predominant irritable bowel syndrome (IBS) were evaluated in a randomized, double-blind, placebo-controlled study." | 5.07 | "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. ( Milo, R; Toussaint, J; Van Eeghem, P; Van Outryve, M, 1991) |
| "Cisapride has well-documented prokinetic effects and may be well suited for long-term therapy of GORD, but its effectiveness in purely symptomatic treatment is unknown." | 2.68 | The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease. ( Carling, L; Hatlebakk, JG; Johnsson, F; Thøgersen, T; Vilien, M; Wetterhus, S, 1997) |
| "Cisapride was well tolerated." | 2.67 | Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients. ( Cochran, KM; Penney, SC; Wood, SF, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (90.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassotti, G | 1 |
| Sietchiping-Nzepa, F | 1 |
| de Roberto, G | 1 |
| Castellani, D | 1 |
| Morelli, A | 1 |
| Wang, B | 1 |
| Liang, X | 1 |
| Jia, B | 1 |
| Wood, SF | 1 |
| Penney, SC | 1 |
| Cochran, KM | 1 |
| Haycox, A | 1 |
| Schütze, K | 1 |
| Brandstätter, G | 1 |
| Dragosics, B | 1 |
| Judmaier, G | 1 |
| Hentschel, E | 1 |
| Hatlebakk, JG | 1 |
| Johnsson, F | 1 |
| Vilien, M | 1 |
| Carling, L | 1 |
| Wetterhus, S | 1 |
| Thøgersen, T | 1 |
| Pizzo, BA | 1 |
| Pisters, KM | 1 |
| Miller, VA | 1 |
| Grant, SC | 1 |
| Baltzer, L | 1 |
| Hinckley, L | 1 |
| Kris, MG | 1 |
| Mayer, EA | 1 |
| Lembo, T | 1 |
| Chang, L | 1 |
| Sanger, GJ | 1 |
| Van Outryve, M | 1 |
| Milo, R | 1 |
| Toussaint, J | 1 |
| Van Eeghem, P | 1 |
2 reviews available for cisapride and Abdominal Pain
| Article | Year |
|---|---|
Approaches to the modulation of abdominal pain.
Topics: Abdominal Pain; Animals; Antidepressive Agents, Tricyclic; Cisapride; Colonic Diseases, Functional; | 1999 |
Hypersensitivity and hyperreactivity in the irritable bowel syndrome: An opportunity for drug discovery.
Topics: Abdominal Pain; Afferent Pathways; Animals; Cisapride; Colonic Diseases, Functional; Constipation; D | 1999 |
6 trials available for cisapride and Abdominal Pain
| Article | Year |
|---|---|
[A controlled multi-centre clinical trial on cisapride in treatment of functional dyspepsia].
Topics: Abdominal Pain; Adolescent; Adult; Aged; Cisapride; Diarrhea; Dyspepsia; Female; Humans; Male; Middl | 1995 |
Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients.
Topics: Abdominal Pain; Adult; Aged; Chronic Disease; Cisapride; Double-Blind Method; Dyspepsia; Family Prac | 1993 |
Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Cisapride; Colonic Diseases, Functional; Constipation; Doub | 1997 |
The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease.
Topics: Abdominal Pain; Cisapride; Constipation; Diarrhea; Drug Administration Schedule; Endoscopy; Esophagi | 1997 |
Oral cisapride for the control of delayed vomiting following high-dose cisplatin.
Topics: Abdominal Pain; Administration, Oral; Aged; Antiemetics; Antineoplastic Agents; Cisapride; Cisplatin | 1999 |
"Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Cisapride; Colonic Diseases, Functional; Constipation; Defe | 1991 |
2 other studies available for cisapride and Abdominal Pain
| Article | Year |
|---|---|
Pseudo-pseudo-obstruction.
Topics: Abdominal Pain; Chronic Disease; Cisapride; Diagnosis, Differential; Female; Gastrointestinal Agents | 2004 |
[Management of dyspepsia. Management plan aimed at prevention of upper abdominal complaints].
Topics: Abdominal Pain; Anti-Ulcer Agents; Cisapride; Dyspepsia; Esophagitis, Peptic; Humans; Piperidines | 1996 |